Corey Davis | IR, LifeSci Advisors |
Dr. Harlan Weisman | CEO |
Dr. Zamaneh Mikhak | Chief Medical Officer |
Kirk Coleman | CFO |
Jonathan Aschoff | ROTH MKM |
Justin Walsh | JonesTrading |
Vernon Bernardino | H.C. Wainwright |
Daniel Carlson | Tailwinds |
Good morning, ladies and gentlemen, and welcome to the TFF Pharmaceuticals Second Quarter 2023 Corporate Update and Earnings Conference Call.
As a reminder, this conference is being recorded.
I will now turn the call over to your host, Corey Davis of LifeSci Advisors.
You may begin your conference.
Thank you, operator.